Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7393 p345
25 March 2006

This article
Reprint   Photocopy

PDF 50K, Acrobat Reader

Letters

· EPS
· Public health
· Supervision
· Assisted dying
· Paracetamol
· FDCs
· Branded prescribing
· Methadone mixture
· Incontinence products
· CPD
· The Society (2)


Letters to the Editor

Assisted dying

Does not comply with duty of care

From Miss H. M. Shaw, MRPharmS

Although British doctors have apparently dropped their long-held opposition to physician-assisted dying (PJ, 21 January, p68), this appears to be the result of an unannounced vote held at the end of the British Medical Association’s conference, when many people had already left.

Members of organisations who are frequently dealing with the terminally ill, ie, the Royal College of Nursing, the Royal College of General Practitioners, the Royal College of Physicians, the British Geriatrics Society and palliative care organisations, are among those opposed to physician-assisted suicide. It is clear that palliative care has reduced suffering enormously and good practice needs to be standardised throughout Britain; this is where pharmacists have a big part to play. These organisations have also highlighted the fact that the duty of a physician to care for his or her patient is incompatible with a duty to bring about death — even at the request of a patient.

Assisted dying changes the relationship between the health professional and patient and the role of medicine in society. Once quality of life becomes the yardstick by which the value of human life is judged, the protection offered to the most vulnerable members of society, eg, the mentally ill, the elderly, the disabled and dying, is weakened. I have seen this recently, with respect to a 53-year-old man with chronic symptoms of schizophrenia, cardiac problems and lacking capacity to make decisions about his treatment. A senior house officer stated that we should consider a “do not resuscitate” policy for him — in his view the patient did not have much to live for. The assisted suicide bill will not serve people like this patient well. It is not easy to evaluate the case of someone considering ending their life and many making this decision are influenced by a feeling of being a burden to family and society.

It is obvious that pharmacists need to make their own minds up about assisted suicide and face the issues, taking into account that medicines are intended to relieve symptoms and cure illness, not take away lives. We must not think that it is the responsibility of the person prescribing. When we dispense medicines we are accountable for our actions and have a clinical responsibility towards the patient. I am regularly involved with patients who want to end their lives; I do not consider it a duty of care to facilitate this by supplying them with medicines to assist them to die.

Helen Shaw
Lead Clinical Pharmacist
Oxfordshire Mental Health

Send your letter to The Editor

Previous Topic (Supervision)
Next Topic (Paracetamol)

Back to Top


©The Pharmaceutical Journal